Skip to content

Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

  • About
    • Supporter
    • Expert Index
    • Editorial Board
    • Editorial Team
    • Editorial Policy
  • Contact
  • Sign up

Visit

vjdementia
VJNeurology
Logo
  • Home (current)
  • Diseases
    Parkinson's Disease
    Multiple Sclerosis and Related Disorders
    Headache
    Amyotrophic Lateral Sclerosis
    Epilepsy
    Sleep Disorders
    Stroke
    Neuromuscular Disorders
    Movement Disorders
    View all Diseases
  • Topics
    Biology
    Diagnostics
    Trial Updates
    Treatment
    Prevention
    Surgery
    Imaging
    Genetics
    COVID-19
    View all Topics
  • Conferences
    AAN 2023
    BNA 2023
    AD/PD 2023
    CONy 2023
    ACTRIMS 2023
    ISC 2023
    View all Conferences
  • Features
  • Podcasts
    • About
      • Supporter
      • Expert Index
      • Editorial Board
      • Editorial Team
      • Editorial Policy
    • Contact
    • Sign up

Uwe Reuter

Discontinuation and reinitiation of migraine treatment with GCRP mAbs 1:13
Discontinuation and reinitiation of migraine treatment with GCRP mAbs
Uwe Reuter • 25 Jun 2022
REGAIN trial of galcanezumab in chronic migraine 1:18
REGAIN trial of galcanezumab in chronic migraine
Uwe Reuter • 25 Jun 2022
Unmet needs in migraine: addressing inter-ictal burden 1:51
Unmet needs in migraine: addressing inter-ictal burden
Uwe Reuter • 25 Jun 2022
Challenges in migraine management 2:09
Challenges in migraine management
Uwe Reuter • 22 May 2020
The evolving landscape of migraine treatment and prevention 3:42
The evolving landscape of migraine treatment and prevention
Uwe Reuter • 22 May 2020
Fremanezumab in patients with chronic or episodic migraine 2:52
Fremanezumab in patients with chronic or episodic migraine
Uwe Reuter • 22 May 2020
HER-MES study: erenumab versus topiramate in episodic migraine 2:30
HER-MES study: erenumab versus topiramate in episodic migraine
Uwe Reuter • 22 May 2020
LIBERTY trial: erenumab in episodic migraine patients with prior preventive treatment failures 2:33
LIBERTY trial: erenumab in episodic migraine patients with prior preventive treatment failures
Uwe Reuter • 22 May 2020
Journal Pages
  • Diseases
  • Topics
  • Medicines
  • Trials
  • Conferences
  • Features
Newsletter

Receive the latest news and videos from VJNeurology via email

Sign up
Contact Us

Contact us for more information

mmp logo

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

VJNeurology logo
The content of VJNeurology is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use
  • Editorial Policy